share_log

Actuate Therapeutics, Inc IPOs Tomorrow, Here's What You Need To Know

明日はアクチュエート・セラピューティクス社のipoです。知っておくべきことはこれです。

Benzinga ·  07/23 11:00

Actuate Therapeutics, Inc (NASDAQ:ACTU) IPO will take place July, 24 on the NASDAQ exchange under the ticker ACTU.

The company is offering shares at an expected price between $8.00 and $10.00 per share with an insider lock-up period of 180 days ending on January 20, 2025.

See also: Benzinga IPO Calendar

About Actuate Therapeutics, Inc

Actuate Therapeutics, Inc is a clinical stage biopharmaceutical company focused on developing therapies for the treatment of high impact, difficult to treat cancers through the inhibition of glycogen synthase kinase-3

See also: Benzinga's Most Shorted Stocks

This article was generated by Benzinga's automated content engine and reviewed by an editor.

これらの内容は、情報提供及び投資家教育のためのものであり、いかなる個別株や投資方法を推奨するものではありません。 更に詳しい情報
    コメントする